Comparing phytopharmaceuticals: The example of St. John’s Wort
Author:
- 1 January 2001
- journal article
- Published by Springer Nature in Advances in Therapy
- Vol. 18 (1) , 35-46
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comparison of St John's wort and imipramine for treating depression: randomised controlled trialBMJ, 2000
- Equivalence of St Johnʼs wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mildmoderate depressionInternational Clinical Psychopharmacology, 2000
- A double-blind randomised trial to investigate three different concentrations of a standardised fresh plant extract obtained from the shoot tips of Hypericum perforatum L.Phytomedicine, 1999
- Extracts and Constituents ofHypericum PerforatumInhibit the Binding of Various Ligands to Recombinant Receptors Expressed with the Semliki Forest Virus SystemJournal of Receptors and Signal Transduction, 1999
- Solubilized Hypericin and Pseudohypericin fromHypericum perforatumExert Antidepressant Activity in the Forced Swimming Test3Planta Medica, 1998
- Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre studyHuman Psychopharmacology: Clinical and Experimental, 1998
- Controlled Clinical Trials of Hypericum Extracts in Depressed Patients - an OverviewPharmacopsychiatry, 1997
- Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of HypericumPharmaceutica Acta Helvetiae, 1997
- Rationale Phytotherapie1996
- High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitroBiochemical Pharmacology, 1988